159 related articles for article (PubMed ID: 8813610)
1. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
Hornfeldt CS; Kitto KF; Larson AA
Eur J Pharmacol; 1996 Jun; 306(1-3):15-22. PubMed ID: 8813610
[TBL] [Abstract][Full Text] [Related]
2. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Larson AA; Sun X
Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
[TBL] [Abstract][Full Text] [Related]
5. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Monnet FP; Debonnel G; Bergeron R; Gronier B; de Montigny C
Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
[TBL] [Abstract][Full Text] [Related]
6. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
Bergeron R; de Montigny C; Debonnel G
Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
[TBL] [Abstract][Full Text] [Related]
7. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1995 Feb; 672(1-2):83-8. PubMed ID: 7749756
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.
Bergeron R; de Montigny C; Debonnel G
J Neurosci; 1996 Feb; 16(3):1193-202. PubMed ID: 8558248
[TBL] [Abstract][Full Text] [Related]
9. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency.
Monnet FP; Blier P; Debonnel G; de Montigny C
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):32-9. PubMed ID: 1407002
[TBL] [Abstract][Full Text] [Related]
10. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
[TBL] [Abstract][Full Text] [Related]
11. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
Bermack JE; Debonnel G
Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
Monnet FP; Debonnel G; Fournier A; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
14. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
Monnet FP; Debonnel G; de Montigny C
Synapse; 1993 Jan; 13(1):30-8. PubMed ID: 8427011
[TBL] [Abstract][Full Text] [Related]
15. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord.
Hornfeldt CS; Sun X; Larson AA
J Neurosci; 1994 May; 14(5 Pt 2):3364-9. PubMed ID: 7514216
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.
Monnet FP; Debonnel G; Junien JL; De Montigny C
Eur J Pharmacol; 1990 Apr; 179(3):441-5. PubMed ID: 2163857
[TBL] [Abstract][Full Text] [Related]
17. Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones.
Fletcher EJ; Church J; Abdel-Hamid K; MacDonald JF
Br J Pharmacol; 1993 Aug; 109(4):1196-205. PubMed ID: 8401930
[TBL] [Abstract][Full Text] [Related]
18. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
19. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
Velázquez RA; Kitto KF; Larson AA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats.
Skuza G
Pol J Pharmacol; 2000; 52(4):313-6. PubMed ID: 11345488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
